In our lab, we have used a set of AcB/BcA recombinant congenic mouse lines (RCS) derived from CRC-resistant B6 and CRC-susceptible A to identify the genetic determinants responsible for the differential susceptibility of these strains to AOM-induced CRC. The gene discussed is BLNK; the disease is colorectal carcinoma.